Smoking and Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for development of IPF. Furthermore, recent work suggests that smoking may have a detrimental effect on survival of patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Chad K. Oh, Lynne A. Murray, Nestor A. Molfino
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Pulmonary Medicine
Online Access:http://dx.doi.org/10.1155/2012/808260
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849467922990235648
author Chad K. Oh
Lynne A. Murray
Nestor A. Molfino
author_facet Chad K. Oh
Lynne A. Murray
Nestor A. Molfino
author_sort Chad K. Oh
collection DOAJ
description Idiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for development of IPF. Furthermore, recent work suggests that smoking may have a detrimental effect on survival of patients with IPF. The mechanism by which smoking may contribute to the pathogenesis of IPF is largely unknown. However, accumulating evidence suggests that increased oxidative stress might promote disease progression in IPF patients who are current and former smokers. In this review, potential mechanisms by which cigarette smoking affects IPF, the effects of cigarette smoking on accelerated loss of lung function in patients with IPF, key genetic studies evaluating the potential candidate genes and gene-environment (smoking) interaction, diagnosis, and treatment with emphasis on recently closed and ongoing clinical trials are presented.
format Article
id doaj-art-e0ee127c21f94f70a3e3283461b199d0
institution Kabale University
issn 2090-1836
2090-1844
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Pulmonary Medicine
spelling doaj-art-e0ee127c21f94f70a3e3283461b199d02025-08-20T03:25:59ZengWileyPulmonary Medicine2090-18362090-18442012-01-01201210.1155/2012/808260808260Smoking and Idiopathic Pulmonary FibrosisChad K. Oh0Lynne A. Murray1Nestor A. Molfino2MedImmune, LLC., One MedImmune Way, Gaithersburg, MD 20878, USAMedImmune, Ltd., Milstein Building, Granta Park Cambridge, CB21 6GH, UKMedImmune, LLC., One MedImmune Way, Gaithersburg, MD 20878, USAIdiopathic pulmonary fibrosis (IPF) is a disease of unknown etiology with considerable morbidity and mortality. Cigarette smoking is one of the most recognized risk factors for development of IPF. Furthermore, recent work suggests that smoking may have a detrimental effect on survival of patients with IPF. The mechanism by which smoking may contribute to the pathogenesis of IPF is largely unknown. However, accumulating evidence suggests that increased oxidative stress might promote disease progression in IPF patients who are current and former smokers. In this review, potential mechanisms by which cigarette smoking affects IPF, the effects of cigarette smoking on accelerated loss of lung function in patients with IPF, key genetic studies evaluating the potential candidate genes and gene-environment (smoking) interaction, diagnosis, and treatment with emphasis on recently closed and ongoing clinical trials are presented.http://dx.doi.org/10.1155/2012/808260
spellingShingle Chad K. Oh
Lynne A. Murray
Nestor A. Molfino
Smoking and Idiopathic Pulmonary Fibrosis
Pulmonary Medicine
title Smoking and Idiopathic Pulmonary Fibrosis
title_full Smoking and Idiopathic Pulmonary Fibrosis
title_fullStr Smoking and Idiopathic Pulmonary Fibrosis
title_full_unstemmed Smoking and Idiopathic Pulmonary Fibrosis
title_short Smoking and Idiopathic Pulmonary Fibrosis
title_sort smoking and idiopathic pulmonary fibrosis
url http://dx.doi.org/10.1155/2012/808260
work_keys_str_mv AT chadkoh smokingandidiopathicpulmonaryfibrosis
AT lynneamurray smokingandidiopathicpulmonaryfibrosis
AT nestoramolfino smokingandidiopathicpulmonaryfibrosis